{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:20:55Z","timestamp":1790356855021,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.gene.2015.02.009","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T17:15:58Z","timestamp":1423329358000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Canavan disease: An Arab scenario"],"prefix":"10.1016","volume":"560","author":[{"given":"Hatem","family":"Zayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2015.02.009_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0046-8177(73)80098-X","article-title":"Spongy degeneration of the central nervous system (Van Bogaert and Bertrand type; Canavan's disease)","volume":"4","author":"Adachi","year":"1973","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gene.2015.02.009_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.22.2.202","article-title":"Cerebral spongy degeneration of infancy: a biochemical and ultrastructural study of affected twins","volume":"22","author":"Adornato","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2015.02.009_bb0020","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/mt.2013.138","article-title":"A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS gene therapy in canavan mice","volume":"21","author":"Ahmed","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.gene.2015.02.009_bb0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10545-007-0635-6","article-title":"Quantification of N-acetylaspartic acid in urine by LC\u2013MS\/MS for the diagnosis of Canavan disease","volume":"30","author":"Al-Dirbashi","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2015.02.009_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/JMN:13:1-2:47","article-title":"Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes","volume":"13","author":"Baslow","year":"1999","journal-title":"J. Mol. Neurosci."},{"issue":"Suppl 2","key":"10.1016\/j.gene.2015.02.009_bb9000","doi-asserted-by":"crossref","first-page":"A155","DOI":"10.1136\/archdischild-2012-302724.0533","article-title":"533 Canavan disease: a case report from Kuwait","volume":"97","author":"Bin Nakhi","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.gene.2015.02.009_bb0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1073\/pnas.0607817104","article-title":"Structure of aspartoacylase, the brain enzyme impaired in Canavan disease","volume":"104","author":"Bitto","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2015.02.009_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archneurpsyc.1931.02230020085005","article-title":"Schindler's encephalitis periaxialis diffusa","volume":"25","author":"Canavan","year":"1931","journal-title":"Arch. Neurol. Psychiat."},{"key":"10.1016\/j.gene.2015.02.009_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/bcp.12065","article-title":"A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting","volume":"76","author":"Chtarto","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2015.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.clinbiochem.2013.09.004","article-title":"New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion","volume":"46","author":"Di Pietro","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2015.02.009_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40477-014-0108-3","article-title":"Brain ultrasound in Canavan disease","volume":"17","author":"Drera","year":"2014","journal-title":"J. Ultrasound"},{"key":"10.1016\/j.gene.2015.02.009_bb0060","first-page":"9","article-title":"A mutation of aspartoacylase gene in a Turkish patient with Canavan disease","volume":"23","author":"Eke","year":"2012","journal-title":"Genet. Couns."},{"key":"10.1016\/j.gene.2015.02.009_bb0065","first-page":"287","article-title":"The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel","volume":"55","author":"Elpeleg","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajmg.a.20334","article-title":"Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay","volume":"124","author":"Feigenbaum","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10545-013-9663-6","article-title":"Dietary triheptanoin rescues oligodendrocyte loss, dysmyelination and motor function in the nur7 mouse model of Canavan disease","volume":"37","author":"Francis","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2015.02.009_bb0080","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archneurpsyc.1928.02210180041003","article-title":"Progressive degenerative subcortical encephalophaty (Schilder's disease)","volume":"20","author":"Globus","year":"1928","journal-title":"Arch. Neurol. Psychiat."},{"key":"10.1016\/j.gene.2015.02.009_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ejpn.2001.0467","article-title":"Canavan disease: a review of recent developments","volume":"2","author":"Gordon","year":"2001","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0090","first-page":"469","article-title":"Islamic views on some reproductive issues","author":"Hathout","year":"1997"},{"key":"10.1016\/j.gene.2015.02.009_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.02.069","article-title":"Mutational analysis of aspartoacylase: implications for Canavan disease","volume":"1148","author":"Hershfield","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.gene.2015.02.009_bb0100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF01066680","article-title":"Expression of absence-like seizure in tremor rats","volume":"21","author":"Higashiguchi","year":"1991","journal-title":"Behav. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pediatrneurol.2005.04.015","article-title":"Lithium citrate for Canavan disease","volume":"33","author":"Janson","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.20787","article-title":"Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene","volume":"59","author":"Janson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng1093-118","article-title":"Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease","volume":"5","author":"Kaul","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0135","first-page":"34","article-title":"Canavan disease: mutations among Jewish and non-Jewish patients","volume":"55","author":"Kaul","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/humu.1380050313","article-title":"Novel (cys152>arg) missense mutation in an Arab patient with Canavan disease","volume":"5","author":"Kaul","year":"1995","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2015.02.009_bb0145","first-page":"95","article-title":"Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease","volume":"59","author":"Kaul","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/GIM.0b013e31818337a8","article-title":"Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease","volume":"10","author":"Kaya","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2015.02.009_bb0155","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1046\/j.1471-4159.2000.0742512.x","article-title":"Accumulation of N-acetyl-l-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system","volume":"74","author":"Kitada","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2015.02.009_bb0115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ymthe.2005.01.006","article-title":"Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease","volume":"11","author":"Klugmann","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.gene.2015.02.009_bb0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/114.2.979","article-title":"CNS pathology in the neurological mutant rats zitter, tremor and zitter-tremor double mutant (spontaneously epileptic rat, SER)","volume":"114","author":"Kondo","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.gene.2015.02.009_bb0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.neurol.2008.10.027","article-title":"An overview of neurometabolic diseases in Tunisia. A 3-year prospective study","volume":"165","author":"Kraoua","year":"2009","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.gene.2015.02.009_bb0165","first-page":"1250","article-title":"Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population","volume":"57","author":"Kronn","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0170","first-page":"4","article-title":"Long-term follow-up after gene therapy for Canavan disease","volume":"165","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.gene.2015.02.009_bb0175","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10545-009-1155-3","article-title":"Glyceryl triacetate for Canavan disease: a low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model","volume":"32","author":"Madhavarao","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2015.02.009_bb0185","first-page":"143","article-title":"Canavan disease: a first case from Jordan","volume":"4","author":"Masri","year":"2006","journal-title":"J. Pediat. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0195","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ajmg.1320290234","article-title":"Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease","volume":"29","author":"Matalon","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0022-3476(95)70105-2","article-title":"Canavan disease: from spongy degeneration to molecular analysis","volume":"127","author":"Matalon","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2015.02.009_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1521-2254(200005\/06)2:3<165::AID-JGM107>3.0.CO;2-R","article-title":"Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system","volume":"2","author":"Matalon","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.gene.2015.02.009_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molbrainres.2004.12.007","article-title":"Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease","volume":"135","author":"McPhee","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.gene.2015.02.009_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0169-328X(95)00044-S","article-title":"N-acetylaspartate as an acetyl source in the nervous system","volume":"31","author":"Mehta","year":"1995","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.gene.2015.02.009_bb0210","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1471-4159.1987.tb05601.x","article-title":"Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues","volume":"48","author":"Ory-Lavollee","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2015.02.009_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajmg.1320350224","article-title":"Aspartoacylase deficiency and Canavan disease in Saudi Arabia","volume":"35","author":"Ozand","year":"1990","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0215","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/08830738920070010211","article-title":"Neurometabolic diseases at a national referral center: five years experience at the King Faisal Specialist Hospital and Research Centre","volume":"7 Suppl.","author":"Ozand","year":"1992","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3940(91)90368-4","article-title":"Toxicity of N-acetylaspartylglutamate and its protection by NMDA and non-NMDA receptor antagonists","volume":"126","author":"Pai","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.gene.2015.02.009_bb0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-8628(19991126)87:3<273::AID-AJMG17>3.0.CO;2-O","article-title":"Novel missense mutation (Y231C) in a Turkish patient with Canavan disease","volume":"87","author":"Rady","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/ejpn.1999.0256","article-title":"Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease","volume":"4","author":"Rady","year":"2000","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0240","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1212\/WNL.15.2.165","article-title":"Spongy degeneration of white matter: Canavan's sclerosis","volume":"15","author":"Sacks","year":"1965","journal-title":"Neurology"},{"key":"10.1016\/j.gene.2015.02.009_bb0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0304-3940(02)00522-0","article-title":"Adenoviral gene transfer of aspartoacylase into the tremor rat, a genetic model of epilepsy, as a trial gene therapy for inherited epilepsy disorder","volume":"328","author":"Seki","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.gene.2015.02.009_bb0250","first-page":"572","article-title":"The molecular basis of canavan (aspartoacylase deficiency) disease in European non-Jewish patients","volume":"57","author":"Shaag","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0260","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/08830738030180111601","article-title":"Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem","volume":"18","author":"Surendran","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0265","first-page":"253","article-title":"Islamic religion and culture: principles and applications for genetic counseling","volume":"23","author":"Swinford","year":"1987"},{"key":"10.1016\/j.gene.2015.02.009_bb0270","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1055\/s-2005-865865","article-title":"Possible genotype\u2013phenotype correlations in children with mild clinical course of Canavan disease","volume":"36","author":"Tacke","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.gene.2015.02.009_bb0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1471-4159.1995.65010275.x","article-title":"Investigation into the role of N-acteylaspartate in cerebral osmoregulation","volume":"65","author":"Taylor","year":"1995","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.gene.2015.02.009_bb9001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0887-8994(97)00185-9","article-title":"The clinical course of Canavan disease","volume":"18","author":"Traeger","year":"1998","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0290","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1523\/JNEUROSCI.1490-08.2008","article-title":"Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS","volume":"28","author":"Traka","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.gene.2015.02.009_bb0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1399-0004.2007.00934.x","article-title":"Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease. (Letter)","volume":"73","author":"Velinov","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.gene.2015.02.009_bb0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-2005-872878","article-title":"Atypical MRI findings in Canavan disease: a patient with a mild course","volume":"36","author":"Yalcinkaya","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.gene.2015.02.009_bb0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0387-7604(99)00003-0","article-title":"Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings","volume":"21","author":"Zafeiriou","year":"1999","journal-title":"Brain Dev."},{"key":"10.1016\/j.gene.2015.02.009_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-012-9520-z","article-title":"Relationship between enzyme properties and disease progression in Canavan disease","volume":"36","author":"Zano","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2015.02.009_bb0315","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1469-8749.1993.tb11649.x","article-title":"Protracted clinical course for patients with Canavan disease","volume":"35","author":"Zelnik","year":"1993","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.gene.2015.02.009_bb0320","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1023\/A:1022091223498","article-title":"Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease","volume":"25","author":"Zeng","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2015.02.009_bb0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ymgme.2006.05.014","article-title":"Rapid detection of three large novel deletions of the aspartoacylase gene in non-Jewish patients with Canavan disease","volume":"89","author":"Zeng","year":"2006","journal-title":"Mol. Genet. Metab."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111915001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111915001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T11:28:56Z","timestamp":1537874936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111915001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0378111915001444"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2015.02.009","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canavan disease: An Arab scenario","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2015.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}